4.7 Review

Superparamagnetic iron oxides as MPI tracers: A primer and review of early applications

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 138, 期 -, 页码 293-301

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.addr.2018.12.007

关键词

Magnetic particle imaging; Magnetic resonance imaging; Superparamagnetic iron oxide; Nanoparticles; Tracer; Cell tracking; Molecular imaging

资金

  1. National Institutes of Health [EUREKA R01 DA26299]
  2. Philips Healthcare, Inc.

向作者/读者索取更多资源

Magnetic particle imaging (MPI) has recently emerged as a non-invasive, whole body imaging technique that detects superparamagnetic iron oxide (SPIO) nanoparticles similar as those used in magnetic resonance imaging (MRI). Based on tracer hot spot detection instead of providing contrast on MRI scans, MPI has already proven to be truly quantitative. Without the presence of endogenous background signal, MPI can also be used in certain tissues where the endogenous MRI signal is too low to provide contrast. After an introduction to the history and simplified principles of MPI, this review focuses on early MPI applications including MPI cell tracking, multiplexed MPI, perfusion and tumor MPI, lung MPI, functional MPI, and MPI-guided hyperthermia. While it is too early to tell if MPI will become a mainstay imaging technique with the (theoretical) sensitivity that it promises, and if it can successfully compete with SPIO-based H-1 MRI and perfluorocarbon-based F-19 MRI, it provides unprecedented opportunities for exploring new nanoparticle-based imaging applications. (C) 2018 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据